199 related articles for article (PubMed ID: 25074869)
41. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*.
MacLaren R; Campbell J
Crit Care Med; 2014 Apr; 42(4):809-15. PubMed ID: 24365863
[TBL] [Abstract][Full Text] [Related]
42. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
[TBL] [Abstract][Full Text] [Related]
43. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
Holtmann G; Layer P; Goebell H
Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
[TBL] [Abstract][Full Text] [Related]
44. Stress ulcer prophylaxis: friend or foe?
Macdonald JJ; Roberts JC; Washington S
Br J Hosp Med (Lond); 2012 Apr; 73(4):238. PubMed ID: 22585209
[No Abstract] [Full Text] [Related]
45. [Proton pump inhibitor H2 receptor antagonist].
Shiotani A; Kamada T; Kusunoki H; Manabe N; Haruma K
Nihon Rinsho; 2011 Jun; 69(6):1032-8. PubMed ID: 21688623
[TBL] [Abstract][Full Text] [Related]
46. Stress-related mucosal disease: risk factors and prophylactic therapy.
Spirt MJ
Clin Ther; 2004 Feb; 26(2):197-213. PubMed ID: 15038943
[TBL] [Abstract][Full Text] [Related]
47. A multicentre feasibility study evaluating stress ulcer prophylaxis using hospital-based registry data.
Litton E; Eastwood GM; Bellomo R; Beasley R; Bailey MJ; Forbes AB; Gattas DJ; Pilcher DV; Webb SA; McGuinness SP; Saxena MK; McArthur CJ; Young PJ
Crit Care Resusc; 2014 Sep; 16(3):158-63. PubMed ID: 25161016
[TBL] [Abstract][Full Text] [Related]
48. Acid suppression in critically ill patients: what does the evidence support?
Spirt MJ
Pharmacotherapy; 2003 Oct; 23(10 Pt 2):87S-93S. PubMed ID: 14587963
[TBL] [Abstract][Full Text] [Related]
49. Review article: prevention of stress-related mucosal bleeding with proton-pump inhibitors.
Maton PN
Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():45-52. PubMed ID: 16303037
[TBL] [Abstract][Full Text] [Related]
50. Acid Suppressive Therapy for Stress Ulcer Prophylaxis in Noncritically Ill Patients.
Hong MT; Monye LC; Seifert CF
Ann Pharmacother; 2015 Sep; 49(9):1004-8. PubMed ID: 26139638
[TBL] [Abstract][Full Text] [Related]
51. Stress ulcer prophylaxis in the intensive care unit trial: detailed statistical analysis plan.
Krag M; Perner A; Wetterslev J; Lange T; Wise MP; Borthwick M; Bendel S; Pelosi P; Keus F; Guttormsen AB; Schefold JC; Meyhoff TS; Marker S; Møller MH
Acta Anaesthesiol Scand; 2017 Aug; 61(7):859-868. PubMed ID: 28608496
[TBL] [Abstract][Full Text] [Related]
52. Effects of stress ulcer prophylaxis in adult ICU patients receiving renal replacement therapy (Sup-Icu RENal, SIREN): Study protocol for a pre-planned observational study.
Schefold JC; Perner A; Lange T; Wetterslev J; Wise MP; Borthwick M; Bendel S; Keus F; Guttormsen AB; Marker S; Krag M; Møller MH;
Trials; 2018 Jan; 19(1):26. PubMed ID: 29321041
[TBL] [Abstract][Full Text] [Related]
53. Prophylactic use of acid suppressants in adult acutely ill hospitalised patients: A systematic review with meta-analysis and trial sequential analysis.
Marker S; Barbateskovic M; Perner A; Wetterslev J; Jakobsen JC; Krag M; Granholm A; Anthon CT; Møller MH
Acta Anaesthesiol Scand; 2020 Jul; 64(6):714-728. PubMed ID: 32060905
[TBL] [Abstract][Full Text] [Related]
54. Are there indications for intravenous acid-inhibition in the prevention and treatment of upper GI bleeding?
Geus WP
Scand J Gastroenterol Suppl; 2000; (232):10-20. PubMed ID: 11232484
[TBL] [Abstract][Full Text] [Related]
55. Stress ulcer prophylaxis for critically ill children: routine use needs to be re-examined.
Abu El-Ella SS; El-Mekkawy MS; Mohamed Selim A
An Pediatr (Engl Ed); 2022 May; 96(5):402-409. PubMed ID: 35701033
[TBL] [Abstract][Full Text] [Related]
56. Stress Ulcer Prophylaxis in Cardiac Surgery: A Retrospective Cohort Study to Analyze the Effects of SUP Cessation.
Mekhail A; Young P; Mekhail AM; Tinawi G; Haran C; Clayton N; Galvin S
J Intensive Care Med; 2023 Oct; 38(10):917-921. PubMed ID: 37093762
[TBL] [Abstract][Full Text] [Related]
57. Enteral nutrition as stress ulcer prophylaxis in critically ill patients: A randomized controlled exploratory study.
El-Kersh K; Jalil B; McClave SA; Cavallazzi R; Guardiola J; Guilkey K; Persaud AK; Furmanek SP; Guinn BE; Wiemken TL; Alhariri BC; Kellie SP; Saad M
J Crit Care; 2018 Feb; 43():108-113. PubMed ID: 28865339
[TBL] [Abstract][Full Text] [Related]
58. What is the optimum prophylaxis against gastrointestinal haemorrhage for patients undergoing adult cardiac surgery: histamine receptor antagonists, or proton-pump inhibitors?
Patel AJ; Som R
Interact Cardiovasc Thorac Surg; 2013 Mar; 16(3):356-60. PubMed ID: 23208652
[TBL] [Abstract][Full Text] [Related]
59. Preventing the gastrointestinal consequences of stress-related mucosal disease.
Metz DC
Curr Med Res Opin; 2005 Jan; 21(1):11-8. PubMed ID: 15881471
[TBL] [Abstract][Full Text] [Related]
60. Gastrointestinal prophylaxis in critically ill patients.
Singh H; Houy TL; Singh N; Sekhon S
Crit Care Nurs Q; 2008; 31(4):291-301. PubMed ID: 18815475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
